Literature DB >> 26906508

Targeting PTEN interactions for Alzheimer's disease.

Samuel Frere1, Inna Slutsky1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26906508     DOI： 10.1038/nn.4248

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  15 in total

Review 1.  PTEN signaling in autism spectrum disorders.

Authors:  Jing Zhou; Luis F Parada
Journal:  Curr Opin Neurobiol       Date:  2012-06-02       Impact factor: 6.627

2.  PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent long-term depression.

Authors:  Sandra Jurado; Marion Benoist; Argentina Lario; Shira Knafo; Cortney N Petrok; José A Esteban
Journal:  EMBO J       Date:  2010-07-13       Impact factor: 11.598

3.  PTEN recruitment controls synaptic and cognitive function in Alzheimer's models.

Authors:  Shira Knafo; Cristina Sánchez-Puelles; Ernest Palomer; Igotz Delgado; Jonathan E Draffin; Janire Mingo; Tina Wahle; Kanwardeep Kaleka; Liping Mou; Inmaculada Pereda-Perez; Edvin Klosi; Erik B Faber; Heidi M Chapman; Laura Lozano-Montes; Ana Ortega-Molina; Lara Ordóñez-Gutiérrez; Francisco Wandosell; Jose Viña; Carlos G Dotti; Randy A Hall; Rafael Pulido; Nashaat Z Gerges; Andrew M Chan; Mark R Spaller; Manuel Serrano; César Venero; José A Esteban
Journal:  Nat Neurosci       Date:  2016-01-18       Impact factor: 24.884

Review 4.  Linking lipids to Alzheimer's disease: cholesterol and beyond.

Authors:  Gilbert Di Paolo; Tae-Wan Kim
Journal:  Nat Rev Neurosci       Date:  2011-03-30       Impact factor: 34.870

5.  AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.

Authors:  Helen Hsieh; Jannic Boehm; Chihiro Sato; Takeshi Iwatsubo; Taisuke Tomita; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2006-12-07       Impact factor: 17.173

6.  Reduced IGF-1 signaling delays age-associated proteotoxicity in mice.

Authors:  Ehud Cohen; Johan F Paulsson; Pablo Blinder; Tal Burstyn-Cohen; Deguo Du; Gabriela Estepa; Anthony Adame; Hang M Pham; Martin Holzenberger; Jeffery W Kelly; Eliezer Masliah; Andrew Dillin
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

7.  PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations.

Authors:  Lia Baki; Junichi Shioi; Paul Wen; Zhiping Shao; Alexander Schwarzman; Miguel Gama-Sosa; Rachael Neve; Nikolaos K Robakis
Journal:  EMBO J       Date:  2004-06-10       Impact factor: 11.598

8.  Overexpression of calcium-activated potassium channels underlies cortical dysfunction in a model of PTEN-associated autism.

Authors:  Pablo Garcia-Junco-Clemente; David K Chow; Elaine Tring; Maria T Lazaro; Joshua T Trachtenberg; Peyman Golshani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

9.  Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β.

Authors:  Jihoon Jo; Daniel J Whitcomb; Kimberly Moore Olsen; Talitha L Kerrigan; Shih-Ching Lo; Gilles Bru-Mercier; Bryony Dickinson; Sarah Scullion; Morgan Sheng; Graham Collingridge; Kwangwook Cho
Journal:  Nat Neurosci       Date:  2011-03-27       Impact factor: 24.884

Review 10.  Subcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disorders.

Authors:  Patricia Kreis; George Leondaritis; Ivo Lieberam; Britta J Eickholt
Journal:  Front Mol Neurosci       Date:  2014-04-01       Impact factor: 5.639
View more
  5 in total

1.  Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease.

Authors:  Tanusree Sen; Pampa Saha; Tong Jiang; Nilkantha Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-12       Impact factor: 11.205

2.  A126 in the active site and TI167/168 in the TI loop are essential determinants of the substrate specificity of PTEN.

Authors:  Michael G Leitner; Kirstin Hobiger; Angeliki Mavrantoni; Anja Feuer; Johannes Oberwinkler; Dominik Oliver; Christian R Halaszovich
Journal:  Cell Mol Life Sci       Date:  2018-07-09       Impact factor: 9.261

Review 3.  Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer's Disease.

Authors:  Muhammad Shahid Nadeem; Salman Hosawi; Sultan Alshehri; Mohammed M Ghoneim; Syed Sarim Imam; Bibi Nazia Murtaza; Imran Kazmi
Journal:  Biomolecules       Date:  2021-11-04

Review 4.  The Akt pathway in oncology therapy and beyond (Review).

Authors:  George Mihai Nitulescu; Maryna Van De Venter; Georgiana Nitulescu; Anca Ungurianu; Petras Juzenas; Qian Peng; Octavian Tudorel Olaru; Daniela Grădinaru; Aristides Tsatsakis; Dimitris Tsoukalas; Demetrios A Spandidos; Denisa Margina
Journal:  Int J Oncol       Date:  2018-10-16       Impact factor: 5.650

5.  MicroRNA-Target Interaction Regulatory Network in Alzheimer's Disease.

Authors:  Aleksander Turk; Tanja Kunej; Borut Peterlin
Journal:  J Pers Med       Date:  2021-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.